Neuronal voltage-gated potassium channel complex autoimmunity in children

Area of Science:

• Neuroimmunology
• Pediatric Neurology
• Autoimmune Disorders

Background:

• Autoimmunity targeting voltage-gated potassium channel complexes is not well-documented in pediatric populations.
• Identifying such cases is crucial for understanding and managing autoimmune neurological conditions in children.

Purpose of the Study:

• To systematically document cases of autoimmunity targeting voltage-gated potassium channel complexes in children.
• To describe the clinical spectrum and outcomes of immunotherapy in these pediatric patients.

Main Methods:

• Retrospective review of Neuroimmunology Laboratory records at Mayo Clinic.
• Analysis of serologic evidence for neurologic autoimmunity in pediatric patients.
• Clinical information review for identified seropositive children.

Main Results:

• Twelve seropositive children were identified, with diverse subacute and multifocal neurologic manifestations including developmental regression, movement disorders, and seizures.
• One child was diagnosed with neoplasia.
• Immunotherapy led to improvement in all treated children, with relapses occurring in 3 of 6 after cessation of treatment.

Conclusions:

• Autoimmunity targeting neuronal potassium channel complexes in children presents a diverse clinical spectrum.
• Early immunotherapy is beneficial, but relapses are common upon discontinuation of treatment.
• Diagnostic delays occur due to the need to rule out neurodegenerative causes.